Comparison of benzodiazepine (BZ) receptor agonists in two rodent activity tests

被引:12
作者
Bayley, PJ
Bentley, GD
Jackson, A
Williamson, D
Dawson, GR
机构
[1] Merck Sharp and Dohme Res. Labs., Neuroscience Research Centre, Harlow, Essex CM20 2QR, Terlings Park, Eastwick Road
[2] Lab. of Experimental Psychology, School of Biological Sciences, University of Sussex, Falmer, Brighton
关键词
diazepam; FG; 8205; flumazenil; quazepam; sedation; zolpidem;
D O I
10.1177/026988119601000305
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The effects of four BZ receptor ligands in an operant test were compared with a rotarod test. In the operant test, rats were trained to pull a chain on a schedule that regulates the probability of delivery of food pellets to maintain a steady chain-pulling rate across alh test session. For the rotarod test, mice were trained to remain on a rotarod for 2 min. Diazepam (0.1-3.0 mg/kg, i.p) FG 8205 (0.1-3.0 mg/kg, i.p) quazepam (3.0-60.0 mg/kg, i.p.) and zolpidem (0.3-10.0 mg/kg, i.p.) each produced dose-related impairments of performance in both the chain-pulling test and the mouse rotarod test. Furthermore, the impairment in performance induced by FG 8205 (10.0 mg/kg, p.o.) was dose-dependently reversed by the BZ receptor antagonist, flumazenil (1.0-10.0 mg/kg, i.p.), indicating that the chain-pulling deficit was mediated via BZ receptor activation. Diazepam, FG 8205 and quazepam all had comparable potencies in both the rotarod assay and the chain-pulling test. However, zolpidem suppressed the chain-pulling rates at a dose 30-fold lower than that required to induce a significant deficit in the rotarod performance. As zolpidem is a preferentially sedative compound, this pattern of results is consistent with the hypothesis that the chain-pulling test is sensitive to sedation induced by BZ receptor agonists.
引用
收藏
页码:206 / 213
页数:8
相关论文
共 34 条
  • [1] PHARMACOLOGICAL PROFILE OF THE IMIDAZOPYRIDINE ZOLPIDEM AT BENZODIAZEPINE RECEPTORS AND ELECTROCORTICOGRAM IN RATS
    ARBILLA, S
    DEPOORTERE, H
    GEORGE, P
    LANGER, SZ
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1985, 330 (03) : 248 - 251
  • [2] BENAVIDES J, 1988, J PHARMACOL EXP THER, V245, P1033
  • [3] BOURIN M, 1992, J PSYCHIATR NEUROSCI, V17, P72
  • [4] LIGANDS FOR BENZODIAZEPINE RECEPTORS WITH POSITIVE AND NEGATIVE EFFICACY
    BRAESTRUP, C
    HONORE, T
    NIELSEN, M
    PETERSEN, EN
    JENSEN, LH
    [J]. BIOCHEMICAL PHARMACOLOGY, 1984, 33 (06) : 859 - 862
  • [5] GABA-A RECEPTOR SUBTYPES - FROM PHARMACOLOGY TO MOLECULAR-BIOLOGY
    BURT, DR
    KAMATCHI, GL
    [J]. FASEB JOURNAL, 1991, 5 (14) : 2916 - 2923
  • [6] CORRADI CL, 1985, SOC NEUR ABSTR, V1, P425
  • [7] DAWSON GR, 1990, Q J EXP PSYCHOL-B, V42, P225
  • [8] DAWSON GR, 1995, PSYCHOPHARMACOLOGY, V113, P570
  • [9] MULTIPLE BENZODIAZEPINE RECEPTORS - NO REASON FOR ANXIETY
    DOBLE, A
    MARTIN, IL
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1992, 13 (02) : 76 - 81
  • [10] A NOTE ON A SIMPLE APPARATUS FOR DETECTING NEUROLOGICAL DEFICIT IN RATS AND MICE
    DUNHAM, NW
    MIYA, TS
    [J]. JOURNAL OF THE AMERICAN PHARMACEUTICAL ASSOCIATION, 1957, 46 (03): : 208 - 209